ALPS Medical Breakthroughs ETF
SBIO
#2250
ETF rank
ยฃ0.15 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
ยฃ48.51
Share price
1.11%
Change (1 day)
96.87%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of July 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of July 2026: 0.5%